Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ANTX

(ANTX) (ANTX) Stock Price, News & Analysis

(ANTX) logo

About (ANTX) Stock (NYSE:ANTX)

Advanced Chart

Key Stats

Today's Range
$1.22
$1.26
50-Day Range
N/A
52-Week Range
$0.87
$2.74
Volume
83,337 shs
Average Volume
360,333 shs
Market Capitalization
$31.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00
Consensus Rating
Moderate Buy

Company Overview

Receive ANTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ANTX) and its competitors with MarketBeat's FREE daily newsletter.

ANTX Stock News Headlines

Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live.
AN2 Therapeutics, Inc. (ANTX) Receives a Sell from Evercore ISI
Evercore ISI Reaffirms Their Sell Rating on AN2 Therapeutics, Inc. (ANTX)
See More Headlines

ANTX Stock Analysis - Frequently Asked Questions

(ANTX) (NYSE:ANTX) released its quarterly earnings data on Tuesday, August, 13th. The company reported ($0.48) EPS for the quarter, topping the consensus estimate of ($0.59) by $0.11.

(ANTX) (ANTX) raised $69 million in an initial public offering (IPO) on Friday, March 25th 2022. The company issued 4,600,000 shares at $14.00-$16.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that (ANTX) investors own include Broadcom (AVGO), NVIDIA (NVDA), Adobe (ADBE), CrowdStrike (CRWD), Meta Platforms (META), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

Last Earnings
8/13/2024
Today
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:ANTX
Previous Symbol
NASDAQ:ANTX
CIK
1156093
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$2.00
Low Price Target
$2.00
Potential Upside/Downside
+86.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$64.73 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-57.62%
Return on Assets
-52.08%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.75
Quick Ratio
9.75

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.19 per share
Price / Book
0.26

Miscellaneous

Outstanding Shares
29,880,000
Free Float
23,667,000
Market Cap
$31.97 million
Optionable
Not Optionable
Beta
0.15
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:ANTX) was last updated on 8/13/2025 by MarketBeat.com Staff
From Our Partners